Literature DB >> 18760518

Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis.

Atsuhiro Ichihara1, Norimasa Yamashita, Tomoko Takemitsu, Yuki Kaneshiro, Mariyo Sakoda, Asako Kurauchi-Mito, Hiroshi Itoh.   

Abstract

BACKGROUND: Patients with kidney failure treated with hemodialysis have a high incidence of cardiovascular diseases caused by accelerated arteriosclerosis. However, accurate evaluation of the extent of arteriosclerosis is difficult. This study sought to compare the strength of predictions of arterial fibrosis by using a new parameter, the cardio-ankle vascular index (CAVI), versus pulse wave velocity (PWV) in patients with kidney failure treated with hemodialysis. STUDY
DESIGN: Diagnostic test study. SETTING & PARTICIPANTS: 103 patients with kidney failure undergoing surgical construction of an arteriovenous access for hemodialysis therapy. INDEX TEST: CAVI and PWV. REFERENCE TEST: Arterial fibrosis, evaluated by using Masson trichrome stain on part of the brachial artery obtained during surgery, expressed as percentage of fibrosis of the layer of vascular smooth muscle cells.
RESULTS: Median percentage of arterial stiffness was 52.85%. Mean PWV and CAVI were 18.3 +/- 5.6 (SD) m/s and 9.9 +/- 2.6, respectively. Multivariate regression analysis showed that arterial fibrosis was significantly associated with older age (0.247%/y; 95% confidence interval, 0.013 to 0.482) and CAVI (6.117%/unit; 95% confidence interval, 4.764 to 4.740), but not with systolic blood pressure (0.039%/mm Hg; 95% confidence interval, -0.076 to 0.153) or PWV (-0.044%/m/s; 95% confidence interval, -0.646 to 0.558). The area under the receiver operating characteristic curve to predict greater than median percentage of arterial stiffness was 0.892 for CAVI and 0.779 for PWV (P = 0.006). LIMITATION: It is unclear whether arterial fibrosis of the brachial artery evaluated by using CAVI is applicable for arteriosclerosis of other arterial districts, and clinical outcomes were not evaluated in this study.
CONCLUSION: CAVI reflects the histological arterial fibrosis of hemodialysis patients and is a useful clinical marker for evaluating arterial stiffness in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18760518     DOI: 10.1053/j.ajkd.2008.06.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

1.  Relationship between coronary artery stenosis and cardio-ankle vascular index (CAVI) in patients undergoing cardiovascular surgery.

Authors:  Masafumi Kanamoto; Naoki Matsumoto; Tatsuya Shiga; Fumio Kunimoto; Shigeru Saito
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

2.  Stiffness parameter β as a predictor of the 4-year all-cause mortality of chronic hemodialysis patients.

Authors:  Masayo Sato; Tetsuya Ogawa; Kuniaki Otsuka; Yoshitaka Ando; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-08-02       Impact factor: 2.801

3.  Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Authors:  Philip M Carlucci; Monica M Purmalek; Amit K Dey; Yenealem Temesgen-Oyelakin; Simantini Sakhardande; Aditya A Joshi; Joseph B Lerman; Alice Fike; Michael Davis; Jonathan H Chung; Martin P Playford; Mohammad Naqi; Pragnesh Mistry; Gustavo Gutierrez-Cruz; Stefania Dell'Orso; Faiza Naz; Taufiq Salahuddin; Balaji Natarajan; Zerai Manna; Wanxia L Tsai; Sarthak Gupta; Peter Grayson; Heather Teague; Marcus Y Chen; Hong-Wei Sun; Sarfaraz Hasni; Nehal N Mehta; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-04-19

Review 4.  The Role of Monitoring Arterial Stiffness with Cardio-Ankle Vascular Index in the Control of Lifestyle-Related Diseases.

Authors:  Kohji Shirai; Atsuhito Saiki; Daiji Nagayama; Ichiro Tatsuno; Kazuhiro Shimizu; Mao Takahashi
Journal:  Pulse (Basel)       Date:  2015-06-20

Review 5.  Arterial Stiffening and Clinical Outcomes in Dialysis Patients.

Authors:  Akihiko Kato
Journal:  Pulse (Basel)       Date:  2015-05-14

Review 6.  Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI).

Authors:  Kohji Shirai; Junji Utino; Atsuhito Saiki; Kei Endo; Masahiro Ohira; Daiji Nagayama; Ichiro Tatsuno; Kazuhiro Shimizu; Mao Takahashi; Akira Takahara
Journal:  Curr Hypertens Rev       Date:  2013-02

7.  Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome.

Authors:  Kanako Bokuda; Atsuhiro Ichihara; Mariyo Sakoda; Asako Mito; Kenichiro Kinouchi; Hiroshi Itoh
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

8.  Assessment of the cardioankle vascular index in pregnant women complicated with hypertensive disorders.

Authors:  Atsushi Yoshida; Takashi Sugiyama; Norimasa Sagawa
Journal:  ISRN Obstet Gynecol       Date:  2011-05-25

9.  Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial).

Authors:  Kenichiro Kinouchi; Atsuhiro Ichihara; Kanako Bokuda; Hideaki Kurosawa; Hiroshi Itoh
Journal:  Int J Hypertens       Date:  2011-06-27       Impact factor: 2.420

10.  Vascular accesses for haemodialysis in the upper arm cause greater reduction in the carotid-brachial stiffness than those in the forearm: study of gender differences.

Authors:  Daniel Bia; Edmundo I Cabrera-Fischer; Yanina Zócalo; Cintia Galli; Sebastián Graf; Rodolfo Valtuille; Héctor Pérez-Cámpos; María Saldías; Inés Alvarez; Ricardo L Armentano
Journal:  Int J Nephrol       Date:  2012-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.